Refractory Hormone Receptor Positive Breast Carcinoma
1 clinical trials · Condition
◉ Watch Refractory Hormone Receptor Positive Breast Carcinoma
| Record | Firm | Date |
|---|---|---|
| Everolimus, Letrozole and Trastuzumab in HR- and HER2/Neu-positive Patients (NCT02152943) | M.D. Anderson Cancer Center | 2014-07-17 |
Track Refractory Hormone Receptor Positive Breast Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.